Outbreak of Invasive Meningococcal Disease in Canterbury, Kent
The UK Health Security Agency (UKHSA) is leading a public health response to an outbreak of invasive meningococcal disease, primarily affecting student populations in Canterbury, Kent. The outbreak has resulted in two fatalities and multiple hospitalizations.
Health officials are distributing preventative antibiotics and implementing a targeted vaccination program.
Outbreak Timeline and Case Details
- The UKHSA was first alerted to a case of Meningitis B by the Queen Elizabeth the Queen Mother Hospital in Margate on March 13.
- Initial investigations linked multiple cases to attendance at Club Chemistry, a nightclub in Canterbury, between March 5 and 7. The venue closed voluntarily.
- Case numbers increased rapidly. As of March 26, the UKHSA reported no new cases in recent days.
- The total number of cases under investigation reached 34, according to multiple sources. The UKHSA confirmed 27 cases in one update, with 15 laboratory-confirmed and 12 under investigation.
- Eleven individuals were reported hospitalized, several described as seriously ill.
Fatalities and Demographics
Two deaths have been confirmed:
- An 18-year-old student, identified in some reports as Juliette Kenny, who was a sixth-form pupil at Queen Elizabeth's Grammar School in Faversham.
- A 21-year-old student from the University of Kent.
The majority of cases involve young adults. Confirmed or suspected cases have been reported at the University of Kent, Canterbury Christ Church University, four schools in Kent, and a higher education institution in London.
Public Health Response
The UKHSA is coordinating a national response with the following key measures:
Antibiotic Distribution: Preventative antibiotics (chemoprophylaxis) have been offered to close contacts of cases and as a precautionary measure. This includes:
- Individuals who attended Club Chemistry on March 5, 6, or 7.
- Students from the University of Kent, including those who have left campus. General Practitioners across England were advised to prescribe antibiotics to these groups.
- Over 6,500 precautionary antibiotic doses have been administered.
Vaccination Program: A targeted vaccination program against the Meningitis B (MenB) strain is underway.
- The program initially focused on students residing in University of Kent halls of residence, with plans to offer 5,000 jabs.
- Approximately 600 MenB vaccines had been administered on the Canterbury campus as of one report.
- Kent and Medway Integrated Care System stated that eligible people can book a second vaccine dose via an online system from April 13.
National Alert: The UKHSA issued an alert to the National Health Service across England, urging clinical staff to be vigilant for symptoms of meningococcal disease. Officials stated this was a precaution and does not indicate nationwide spread.
Disease Information
- Cause: The outbreak is caused by invasive meningococcal disease, a bacterial infection. Laboratory testing has confirmed the involvement of the Meningitis B (MenB) strain in several cases, which is the most common strain of meningococcal disease in the UK.
- Transmission: The bacteria are carried in the nose and throat of approximately 10-24% of the population without causing illness. It spreads through prolonged close contact, such as kissing, coughing, or sharing items like drinks or vapes.
- Symptoms: Early symptoms can include fever, headache, vomiting, diarrhea, muscle pain, drowsiness, and cold hands and feet. A stiff neck, dislike of bright lights, and a rash that does not fade under pressure can develop as the disease progresses. Health officials warn that early symptoms can be mistaken for common illnesses like flu.
- Severity: Invasive meningococcal disease can lead to meningitis (inflammation of the brain and spinal cord linings) and/or septicaemia (blood poisoning). The disease can deteriorate rapidly and is potentially fatal.
- Treatment: Bacterial meningitis is a medical emergency requiring immediate hospital treatment, typically with intravenous antibiotics.
Vaccination Context in the UK
- The MenB vaccine is part of the UK's routine childhood immunization schedule, offered to babies at two, four, and 12 months of age.
- The MenACWY vaccine, which protects against four other strains, is offered to teenagers and first-time university students up to the age of 25.
- UKHSA officials have stated the NHS has sufficient stock of the MenB vaccine. Reports indicated some pharmacies faced shortages of privately purchased MenB jabs.
- A former health minister suggested the government consider a "catch-up" vaccination campaign for young people in light of outbreaks.
Official and Expert Statements
UKHSA Chief Executive Susan Hopkins described the cluster as an "unprecedented" and "explosive" number of cases in a short timeframe, characterizing it as a "super-spreader event."
- Health Secretary Wes Streeting expressed concern about the "pace and extent" of the outbreak but stated there was no concern about national spread during the Easter break.
- Trish Mannes, UKHSA South-East Deputy Director, emphasized the importance of vaccination and public awareness of symptoms, noting the MenB vaccine does not protect against all strains.
- Prof Robin May, UKHSA Chief Scientific Officer, said the scale of the outbreak is under investigation, with factors such as a single spreading event or increased bacterial transmissibility being considered.
Statements from Affected Individuals
- Matt Jewel, a University of Kent student, said a friend was hospitalized but recovered. He noted students are now more aware of meningitis symptoms and that his finances were affected when Club Chemistry closed.
- George Retter, another student, said there was panic and described some news coverage as "a little overdone," but acknowledged people had reason for concern. He confirmed his dissertation deadline was extended by a week.
Candice Skinner, whose daughter Tyra was hospitalized, described the illness as having a "quick and drastic" effect, progressing from flu-like symptoms to intensive care within days. She reported her daughter has recovered and that people are now more cautious about sharing items.